With box warnings

Without box warnings

Branded

Generic

2 results

adbry
(tralokinumab-ldrm)
LEO Pharma Inc.
Usage: ADBRY is indicated for treating moderate-to-severe atopic dermatitis in adults and pediatric patients aged 12 and older when topical therapies are insufficient or inappropriate. It can be used alone or in conjunction with topical corticosteroids.
ebglyss
(lebrikizumab-lbkz)
Eli Lilly and Company
Usage: EBGLYSS is indicated for treating moderate-to-severe atopic dermatitis in adults and pediatric patients aged 12 and older, weighing at least 40 kg, when topical therapies are insufficient or unsuitable. It can be used alone or with topical corticosteroids.

Interleukin-13 Antagonist class drugs

adbry